Recto-vaginal fistula: A refractory complication of Behcet's disease [4]

Colorectal Disease

Volumn 9, Issue 7, 2007, Pages 667-668

  Chawla, Sumita ^a   Smart, C J ^a   Moots, R J ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; INFLIXIMAB; THALIDOMIDE;

ADULT; BEHCET DISEASE; CASE REPORT; COLOSTOMY; EPISIOTOMY; FEMALE; HEALING; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECTOVAGINAL FISTULA; SURGICAL TECHNIQUE; TISSUE FLAP; TREATMENT FAILURE;

ADULT; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; DAPSONE; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; RECTOVAGINAL FISTULA; THALIDOMIDE; TREATMENT OUTCOME;

EID: 34547858881     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2007.01217.x     Document Type: Letter

References (8)

1. Cho MY, Lee SH, Bang D, Lee S. Epidemiologic findings of Behcet's syndrome. Korean J Dermatol 1988; 26: 320-9.
2. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990; 335: 1078-80.
3. Estrach C, Mpofu S, Moots RJ. Behçets Syndrome: Response to infliximab after failure of etanercept. Rheumatology (Oxford) 2002; 41: 1213-4.
4. Sfikakis PP. Behçets disease: A new target for anti-tumour necrosis factor treatment. Ann Rheum 2002: 61 (Suppl. 2): 51-53.
5. Robertson LP, Hickling P. Treatment of recalcitrant orogenital ulceration of Behçets syndrome with infliximab. Rheumatology 2001: 40: 473-4.
6. Rosenbaum M, Rosner I, Portnoy E. Remission of Behcets syndrome with TNF alpha blocking treatment. Ann Rheum 2002; 61: 283-4.
7. Goossens PH, Verburg RJ, Breedveld FC. Remissions of Behcet's syndrome with TNF alpha blocking therapy. Ann Rheum 2001; 60: 637.
8. Anal fistula. Surgical Evaluation and Management (eds Phillips RK, Lunniss PJ). Chapman & Hall Medical, 1996.